Search Results - "Zhao, Lishu"

Update on lymphocyte-activation gene 3 (LAG-3) in cancers: from biological properties to clinical applications by Zhao, Lishu, Wang, Hao, Xu, Kandi, Liu, Xinyue, He, Yayi

“…Immunotherapy that targets checkpoints, especially programmed cell death protein 1 and programmed cell death ligand 1, has revolutionized cancer therapy…”
Get full text

Downregulation of miR-574-5p inhibits HK-2 cell viability and predicts the onset of acute kidney injury in sepsis patients by Liu, Shanshan, Zhao, Lishu, Zhang, Li, Qiao, Lujun, Gao, Shufang

“…Increased levels of microRNA-574-5p (miR-574-5p) have been found to be associated with increased survival of septic patients, indicating the potential role of…”
Get full text

Multiple Primary Lung Cancers: A New Challenge in the Era of Precision Medicine by Zhao, Lishu, Liu, Chaoyuan, Xie, Guiyuan, Wu, Fang, Hu, Chunhong

“…With the widespread implementation of lung cancer screening, more and more patients are being diagnosed with multiple primary lung cancers (MPLCs). In the era…”
Get full text

Spatial heterogeneity of infiltrating immune cells in the tumor microenvironment of non-small cell lung cancer by Liu, Xinyue, Kong, Yan, Qian, Youwen, Guo, Haoyue, Zhao, Lishu, Wang, Hao, Xu, Kandi, Ye, Li, Liu, Yujin, Lu, Hui, He, Yayi

“…•Immune cells showed heterogeneous distribution in TME of NSCLC.•Efficientnet-B3-based model realized tumor and immune region segmentation.•TIME could be…”
Get full text

An immune-based risk-stratification system for predicting prognosis in pulmonary sarcomatoid carcinoma (PSC) by Guo, Haoyue, Li, Binglei, Diao, Li, Wang, Hao, Chen, Peixin, Jiang, Minlin, Zhao, Lishu, He, Yayi, Zhou, Caicun

“…Pulmonary sarcomatoid carcinoma (PSC) is an uncommon subtype of lung cancer, and immune checkpoint blockade promises in clinical benefit. However, virtually…”
Get full text

Efficacy of Naprapathy in Brachial Plexus Injury: Protocol for a Randomized Clinical Trial by Xiao, Bin, Zhao, Lishu, Huang, Yong, Ma, Anqi, Pei, Baoshun, Li, Zhengyu, Gu, Fei

“…Clinical rehabilitation for brachial plexus injury is difficult in terms of chronic pain and dysfunction. Physiotherapy is considered a routine intervention…”
Get full text

Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune Microenvironment by Chen, Peixin, Wang, Hao, Zhao, Lishu, Guo, Haoyue, Zhang, Liping, Zhang, Wei, Sun, Chenglong, Zhao, Sha, Li, Wei, Zhu, Jun, Yu, Jia, Wu, Chunyan, He, Yayi

“…OX40 and OX40 ligand (OX40L), as essential immune checkpoint (IC) modulators, are highly correlated with cancer immunity regulation as well as tumor…”
Get full text

Impact of renin–angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study by Zhong, Yanjun, Zhao, Lishu, Wu, Guobao, Hu, Chunhong, Wu, Chenfang, Xu, Min, Dong, Haiyun, Zhang, Quan, Wang, Guyi, Yu, Bo, Lv, Jianlei, Wu, Chao, Zhang, Siye, Cao, Chenghui, Shu, Long, Pan, Yue, Liu, Xianling, Wu, Fang

“…Objective Association of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) use with coronavirus disease 2019 (COVID-19)…”
Get full text

Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I–III small cell lung cancer by Chen, Peixin, Zhao, Lishu, Wang, Hao, Zhang, Liping, Zhang, Wei, Zhu, Jun, Yu, Jia, Zhao, Sha, Li, Wei, Sun, Chenglong, Wu, Chunyan, He, Yayi, Zhou, Caicun

“…BackgroundImmunotherapy has revolutionized therapeutic patterns of small cell lung cancer (SCLC). Human leukocyte antigen class II (HLA class II) is related to…”
Get full text

Pacemakers and methylprednisolone pulse therapy in immune-related myocarditis concomitant with complete heart block by Hu, Chunhong, Zhao, Lishu, Zhou, Chengzhi, Wang, Hanping, Jiang, Shun, Li, Yizheng, Peng, Yurong, Deng, Chao, Ma, Fang, Pan, Yue, Shu, Long, Huang, Yan, Zeng, Yue, Wu, Fang

“…Immune-related cardiotoxicities are uncommon but potentially fatal. The study aims to evaluate the value of pacemakers and methylprednisolone pulse therapy…”
Get full text

Different response to ALK inhibitors in EML4-ALK positive mediastinal cancer of unknown primary by Hu, Chunhong, Zhao, Lishu, Wu, Fang

“…Abstract only 104 Background: With the development of next-generation sequencing (NGS) and precision medicine, targeted therapy especially molecule-driven…”
Get full text

Smoking related environmental microbes affecting the pulmonary microbiome in Chinese population by Liu, Xinyue, Sun, Wenwen, Ma, Weiqi, Wang, Hao, Xu, Kandi, Zhao, Lishu, He, Yayi

“…Smoking is a serious public health problem that affects human health conditions. Although there is evidence that microorganisms are associated with…”
Get full text

Clinical treatment options for early-stage and advanced conjunctival melanoma by Zeng, Yue, Hu, Chunhong, Shu, Long, Pan, Yue, Zhao, Lishu, Pu, Xingxiang, Wu, Fang

“…Conjunctival melanoma (CM) is an ocular malignant tumor arising from the bulbar and palpebral conjunctiva and from the caruncle. The treatment of early-stage…”
Get full text

New progress of tuberculosis scar carcinoma by Sun, Wenwen, Liu, Yujin, Zhao, Lishu, Wang, Hao, Ye, Li, Liu, Xinyue, Xu, Kandi, Chen, Yu, Fan, Lin

“…It has been demonstrated that scar tissue and fibrosis may increase the likelihood of developing malignancies. Specifically, scar tissue has been linked to the…”
Get full text

Microbes in lung cancer initiation, treatment, and outcome: Boon or bane? by Guo, Haoyue, Zhao, Lishu, Zhu, Junjie, Chen, Peixin, Wang, Hao, Jiang, Minlin, Liu, Xiaogang, Sun, Hui, Zhao, Wencheng, Zheng, Zixuan, Li, Wei, Chen, Bin, Fang, Qiyu, Yang, Menghang, He, Yayi, Yang, Yang

“…Lung cancer is the top reason for cancer-related deaths worldwide. The 5-year overall survival rate of lung cancer is approximately 20 % due to the delayed…”
Get full text

Promising preclinical models for lung cancer research—lung cancer organoids: a narrative review by Chen, Xinru, Ye, Li, Wang, Hao, Liu, Xinyue, Zhao, Lishu, Xu, Kandi, Liu, Yujin, He, Yayi

Get full text

Therapeutic efficacy comparison of six major EGFR-TKIs in non-small-cell lung cancer patients with an activating EGFR mutation: A network meta-analysis by Wu, Fang, He, Jingyi, Wu, Sixuan, Huang, Yan, Li, Yizheng, Zhao, Lishu, Hu, Chunhong

“…Abstract only e20671 Background: EGFR-TKIs are the standard in the first line treatment for patients with advanced NSCLC with EGFR activating mutations.This…”
Get full text

Subgroup-level network meta-analysis for efficacy of first-line immunotherapy-based treatments in advanced non-small cell lung cancer by Wu, Fang, Tian, Wentao, Cao, Chenghui, Ke, Jiawen, Tan, Nuopei, Cai, Yuwen, Zeng, Yue, Pan, Yue, Liu, Xiaohan, Zhao, Lishu, Shu, Long, Liu, Junqi

“…Abstract only 9064 Background: Immunotherapy has unequal efficacies in populations with different clinical or histological features. This study aims to explore…”
Get full text

Update on lymphocyte-activation gene 3 (LAG-3) in cancers: from biological properties to clinical applications by Zhao, Lishu, Wang, Hao, Xu, Kandi, Liu, Xinyue, He, Yayi

Get full text

Identification of recurrence-associated gene signature and tumor immune microenvironment features in resected stage I NSCLC by Wu, Fang, Hu, Chunhong, Shu, Long, Chen, Chen, Fan, Songqing, Liang, Qingchun, Zheng, Hongmei, Pan, Yue, Zhao, Lishu, Zou, Fangwen, Liu, Chaoyuan, Liu, Wenliang, Yu, Fenglei, Liu, Xianling, Liu, Lijuan, Yang, Lingling, Shao, Yang

“…Abstract only 9080 Background: Surgery is the primary treatment for stage I NSCLC, but postoperative recurrence leads to poor prognosis. Alterations of tumor…”
Get full text